Genentech

Roche culls cough candidate, pivots KRAS program after revaluing entire pipeline
Fierce Biotech
Wed, 10/23/24 - 11:29 am
Roche
chronic cough
KRAS
Genentech
Another Roche MAGE-A4 trial disappears, withdrawn without enrolling after strategic review
Fierce Biotech
Fri, 10/18/24 - 11:34 am
Roche
MAGE-A4
clinical trials
solid tumors
bispecific antibodies
Genentech
Genentech buys Regor's next-gen CDK inhibitors for $850M
Pharmaphorum
Tue, 10/1/24 - 09:46 am
Regor Therapeutics
Roche
Genentech
CDK inhibitors
Roche doubles down with another subcutaneous FDA nod, this one for MS star Ocrevus
Fierce Pharma
Sun, 09/15/24 - 06:17 pm
Roche
Genentech
Ocrevus
MS
Ocrevus Zunovo
Genentech's cancer restructure was made 'for scientific reasons': exec
Fierce Biotech
Tue, 09/10/24 - 08:44 am
Genentech
Roche
restructuring
Novartis and Genentech’s Xolair is rising rapidly on TV
Medical Marketing and Media
Thu, 08/29/24 - 06:11 pm
Novartis
Genentech
Xolair
television ads
Genentech telegraphs 93 layoffs in California after sharing plans to shutter cancer immunology research unit
Fierce Biotech
Wed, 08/28/24 - 11:36 am
Genentech
Roche
layoffs
California
Genentech to shut down cancer immunology department amid broader R&D rethink
Fierce Biotech
Fri, 08/16/24 - 11:36 am
Genentech
cancer immunology
Ira Mellman
Sangamo secures $50M upfront in neurodegenerative pact with Roche's Genentech
Fierce Biotech
Tue, 08/6/24 - 11:34 am
Sangamo Therapeutics
Roche
Genentech
neurodegenerative disease
Peloton’s Robin Arzón shines light on MS at Genentech-backed panel
Medical Marketing and Media
Fri, 08/2/24 - 11:41 am
Genentech
pharma marketing
MS
multiple sclerosis
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters
Thu, 06/6/24 - 11:34 am
Novartis
Roche
Genentech
Italy
antitrust
Biogen
Samsung Bioepis
Byooviz
Roche Sees Early ROI on $2.7B Carmot Buy with Phase I Data for Obesity Candidate
BioSpace
Thu, 05/16/24 - 11:40 am
Roche
Genentech
CT-388
Carmot
weight loss
clinical trials
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Genentech experts call for multiple strategies to diversify clinical trials
Clinical Trials Arena
Thu, 05/2/24 - 10:08 pm
Genentech
clinical trials
clinical trial diversity
Roche Trims Four Early Assets as Q1 Sales Slip 6% on Currency, COVID Headwinds
BioSpace
Wed, 04/24/24 - 09:55 am
Roche
Genentech
earnings
Roche, Adaptimmune part ways on cell therapy research
BioPharma Dive
Sun, 04/14/24 - 01:26 pm
Roche
Genentech
cell therapy
cancer
Adaptimmune
Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff
BioSpace
Thu, 04/11/24 - 10:22 pm
biotech
layoffs
Genentech
Sanofi
Novartis
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval
BioSpace
Sun, 03/10/24 - 08:25 pm
Fresenius Kabi
FDA
biosimilars
Actemra
Tyenne
Genentech
Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
Fierce Biotech
Tue, 01/23/24 - 10:43 am
Roche
Genentech
GenEdit
drug development
gene therapy
autoimmune disease

Pages